
The number of deals in UK spinouts at the earliest stage of equity investing has been falling over the past few years, highlighting a potential bottleneck in early-stage funding.
Venture funds are becoming a more common offering at universities around the world. Why do a majority of the top US institutions not have one?
Backed by JPMorgan Chase, Honeywell, Amgen, Mitsui & Co, Quantinuum is working both on quantum hardware and software — and is now one of the biggest players in the field.
GUV is launching a weekly spinout tracker to surface the most exciting new and emerging companies based on university research.
GV backs another spinout by MIT’s serial entrepreneur Feng Zhang as epigenetics becomes an emerging area of healthcare.
Countries like Germany, Switzerland and Japan have benefitted from an explosive growth in capital, but the US still dominates and the UK risks being left behind, our in-depth analysis shows.
Launched just a year ago to build on work at Weill Cornell Medicine and New York-Presbyterian Hospital, Cleerly has now closed an oversubscribed series C round.
Cambridge Enterprise has put cash into CardiaTec Biosciences in a pre-seed round that marks the inaugural deal for Laidlaw Scholars Ventures.
Oxford Quantum Circuits' series A round is already among the largest for a European quantum company and could still go higher.
UT Southwestern Medical Center spinout ReCode Therapeutics has now raised a total of $200m in its series B round from investors including Osage University Partners.
University of Washington spinout Zap Energy is working on building a cheap, scalable fusion reactor generating low cost and carbon free energy.
Osage University Partners has added MicroTransponder to a small but mightly portfolio of medical device companies.
Chalmers spinout Elypta is working on a metabolism-based liquid biopsy for early cancer detection that it hopes will catch any type of the disease.
Orphan CNS therapy developer Minoryx Therapeutics closed a $54.8m series C and MIT's The Engine co-led a $10.5m seed round for Foundation Alloy.
UK smartphone camera component developer Cambridge Mechatronics’ latest round featured strategic investors Sony Ventures and Intel Capital.
Corporate investors have been part of $3bn worth of AI deals so far this year, with June particularly strong. There has also been a uptick in exits.
Corporates continued to invest in real estate tech through 2022, unlike their traditional VC peers. We look at how this might play out.